ProCE Banner Activity

Case Discussion: Advances in Systemic and Targeted Therapies

Slideset Download
Download these slides from a live symposium to learn more about novel systemic and targeted therapy approaches in mCRPC

Released: February 18, 2022

Expiration: February 17, 2023

No longer available for credit.

Share

Faculty

Michael Schweizer

Michael Schweizer, MD

Associate Professor
Clinical Research Division
Department of Medical Oncology
University of Washington
Fred Hutchinson Cancer Research Center
Seattle, Washington

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Bayer Healthcare Pharma

Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC

Novartis Pharmaceuticals Corp Advanced Accelerator Applications

Sanofi Genzyme

Faculty Disclosure

Primary Author

Michael Schweizer, MD

Associate Professor
Clinical Research Division
Department of Medical Oncology
University of Washington
Fred Hutchinson Cancer Research Center
Seattle, Washington

Michael Schweizer, MD, has disclosed that he has received consulting fees from AstraZeneca, PharmaIn, and Sanofi and funds for research support paid to his institution from Ambrx, AstraZeneca, Bristol-Myers Squibb, Hoffmann-La Roche, Immunomedics, Janssen, Madison Vaccines, Merck, Pfizer, SignalOne Bio, Tmunity, and Zenith Epigenetics.